Status:
UNKNOWN
Coagulation Profile in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention
Lead Sponsor:
Centre of Postgraduate Medical Education
Conditions:
Chronic Coronary Insufficiency
Smoking
Eligibility:
All Genders
18-100 years
Brief Summary
The activated clotting time (ACT), global thrombosis test (GTT-3), platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography...
Detailed Description
The activated clotting time (ACT), global thrombosis test (GTT-3) and platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiogra...
Eligibility Criteria
Inclusion
- patients scheduled do CA \>18 years old
Exclusion
- pregnancy
- previous treatment with P2Y12 inhibitors, novel oral anticoagulants (NOAC) or warfarin acenocoumarol in last 24 hours
Key Trial Info
Start Date :
April 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05336669
Start Date
April 30 2022
End Date
August 31 2023
Last Update
April 20 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.